Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Inventory: 2010-2024

Historic Inventory for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $23.8 million.

  • Anika Therapeutics' Inventory fell 58.91% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year decrease of 58.91%. This contributed to the annual value of $23.8 million for FY2024, which is 2.53% down from last year.
  • As of FY2024, Anika Therapeutics' Inventory stood at $23.8 million, which was down 2.53% from $24.4 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Inventory registered a high of $46.2 million during FY2020, and its lowest value of $23.8 million during FY2024.
  • Its 3-year average for Inventory is $29.3 million, with a median of $24.4 million in 2023.
  • As far as peak fluctuations go, Anika Therapeutics' Inventory skyrocketed by 110.09% in 2020, and later slumped by 38.57% in 2023.
  • Yearly analysis of 5 years shows Anika Therapeutics' Inventory stood at $46.2 million in 2020, then fell by 22.07% to $36.0 million in 2021, then grew by 10.43% to $39.8 million in 2022, then tumbled by 38.57% to $24.4 million in 2023, then fell by 2.53% to $23.8 million in 2024.